Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.83
-0.05 (-0.73%)
At close: Aug 29, 2025, 4:00 PM
6.81
-0.02 (-0.29%)
After-hours: Aug 29, 2025, 7:26 PM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
$2,941
Profits / Employee
$420,897
Market Cap
350.23M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 136 | 52 | 61.90% |
Dec 31, 2023 | 84 | 27 | 47.37% |
Dec 31, 2022 | 57 | -33 | -36.67% |
Dec 31, 2021 | 90 | 14 | 18.42% |
Dec 31, 2020 | 76 | -12 | -13.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABEO News
- 3 days ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Abeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond Zevaskyn - Seeking Alpha
- 18 days ago - Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients - GlobeNewsWire
- 6 weeks ago - ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area - GlobeNewsWire
- 7 weeks ago - Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy - PRNewsWire